Caring for children with NAFLD and navigating their care into adulthood

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Reviews Gastroenterology &Hepatology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrgastro.2015.146PMID 26323878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct Evidence of Brown Adipocytes in Different Fat Depots in Children

  2015cited by this paper
• Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis: ESPGHAN Hepatology Committee Position Statement

  2015cited by this paper
• Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)

  2015cited by this paper
• The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese.

  2015cited by this paper
• Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.

  2015cited by this paper
• Child and adolescent obesity: part of a bigger picture.

  2015cited by this paper
• Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery.

  2015cited by this paper
• Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.

  2015cited by this paper
• Su1038 Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Children and Young Adults: The True Burden of Pediatric Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

  2015cited by this paper
• Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

  2015cited by this paper
• Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study

  2015cited by this paper
• The sexual dimorphism of obesity.

  2015cited by this paper
• Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study

  2015cited by this paper
• Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease

  2015cited by this paper
• Non alcoholic fatty liver: epidemiology and natural history.

  2015cited by this paper
• Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.

  2015cited by this paper
• Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study

  2015cited by this paper
• Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

  2015cited by this paper
• Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

  2015cited by this paper
• Weight and Weight-Related Behaviors Among 2-Year College Students

  2015cited by this paper
• Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

  2015cited by this paper
• Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications

  2015cited by this paper
• Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

  2015cited by this paper
• Non‐alcoholic fatty liver disease and hepatocellular carcinoma in a 7‐year‐old obese boy: coincidence or comorbidity?

  2014cited by this paper
• Pathological features of fatty liver disease.

  2014cited by this paper
• Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

  2014cited by this paper
• Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

  2014cited by this paper
• Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.

  2014cited by this paper
• Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

  2014cited by this paper
• Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis

  2014cited by this paper
• Gut microbiota and liver disease

  2014cited by this paper
• The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease

  2014cited by this paper
• Prevalence of childhood and adult obesity in the United States, 2011-2012.

  2014cited by this paper
• Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits

  2014cited by this paper
• Obesity and cancer—mechanisms underlying tumour progression and recurrence

  2014cited by this paper
• Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States

  2014cited by this paper
• Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

  2014cited by this paper
• Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study

  2014cited by this paper
• Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases.

  2014cited by this paper
• Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care.

  2014cited by this paper
• Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease; A Meta-Analysis

  2014cited by this paper
• Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)

  2014cited by this paper
• Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

  2014cited by this paper
• TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

  2014cited by this paper
• Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study

  2014cited by this paper
• Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.

  2014cited by this paper
• Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene

  2014cited by this paper
• The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

  2014cited by this paper
• Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis

  2014cited by this paper
• Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

  2014cited by this paper
• Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.

  2014cited by this paper
• Stakeholder validation of a model of readiness for transition to adult care.

  2013cited by this paper
• Liver steatosis in Polish children assessed by medicolegal autopsies

  2013cited by this paper
• NAFLD in Asia—as common and important as in the West

  2013cited by this paper
• Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis

  2013cited by this paper
• Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery

  2013cited by this paper
• Non‐alcoholic fatty liver disease contributes to hepatocarcinogenesis in non‐cirrhotic liver: A clinical and pathological study

  2013cited by this paper
• Associations between neighborhood resources and physical activity in inner-city minority children.

  2013cited by this paper
• Dietary fructose in nonalcoholic fatty liver disease

  2013cited by this paper
• Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

  2013cited by this paper
• Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Associations of Body Mass Index with Sexual Risk-Taking and Injection Drug Use among US High School Students

  2013cited by this paper
• Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

  2012cited by this paper
• Effect of a 10-week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children

  2012cited by this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Influence of Obstructive Sleep Apnea on Fatty Liver Disease: Role of Chronic Intermittent Hypoxia

  2012cited by this paper
• Fatty liver disease in an autopsy series of children and adolescents.

  2012cited by this paper
• Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents.

  2012cited by this paper
• Association between puberty and features of nonalcoholic fatty liver disease.

  2012cited by this paper
• The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

  2012cited by this paper
• Alcohol drinking patterns and the risk of fatty liver in Japanese men

  2011cited by this paper
• Histopathological characteristics of non‐alcoholic fatty liver disease in children: Comparison with adult cases

  2011cited by this paper
• Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance

  2011cited by this paper
• Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease

  2011cited by this paper
• Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

  2011cited by this paper
• Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

  2011cited by this paper
• Autophagy in nonalcoholic steatohepatitis

  2011cited by this paper
• Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home

  2011cited by this paper
• Pediatric brown adipose tissue: detection, epidemiology, and differences from adults.

  2011cited by this paper
• Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.

  2011cited by this paper
• Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease

  2011cited by this paper
• Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

  2011cited by this paper
• A social-ecological model of readiness for transition to adult-oriented care for adolescents and young adults with chronic health conditions.

  2011cited by this paper
• Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

  2011cited by this paper
• Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

  2011cited by this paper
• The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature.

  2011cited by this paper
• Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

  2010cited by this paper
• Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16 390 overweight or obese children and adolescents

  2010cited by this paper
• Risk factors for liver steatosis in obese children and adolescents.

  2010cited by this paper
• The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

  2010cited by this paper
• Childhood obesity and the built environment

  2010cited by this paper
• The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.

  2010cited by this paper
• Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

  2010cited by this paper
• The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

  2010cited by this paper

• Elastography as a non-invasive method of screening non-alcoholic fatty liver disease in the adult phenotype of paediatric obstructive sleep apnoea

  2024cites this paper
• Pediatric to adult transition care in neurogastroenterology and motility: A position paper from the American Neurogastroenterology and Motility Society and European Society of Neurogastroenterology and Motility

  2024cites this paper
• Association between heavy metal exposure and biomarkers for non-alcoholic fatty liver disease in Korean adolescents

  2024cites this paper
• A global research priority agenda to advance public health responses to fatty liver disease.

  2023cites this paper
• Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study

  2021cites this paper
• Unhealthy Eating, Psychopathology, and Nonalcoholic Fatty Liver Disease in Youth Presenting for Bariatric Surgery

  2021cites this paper
• Metabolic Associated Fatty Liver Disease in Children—From Atomistic to Holistic

  2021cites this paper
• Advancing the global public health agenda for NAFLD: a consensus statement

  2021cites this paper
• Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Метаболические и генетические детерминанты нарушения липидного обмена при неалкогольной жировой болезни печени

  2020cites this paper
• Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Метаболические и генетические детерминанты нарушения липидного обмена при неалкогольной жировой болезни печени Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH

  2019cites this paper
• In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children

  2018cites this paper
• Association between plasminogen activator inhibitor‐1 and severity of liver injury and cardiovascular risk in children with non‐alcoholic fatty liver disease

  2018cites this paper
• Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases

  2018cites this paper
• The Health Care Transition of Youth With Liver Disease Into the Adult Health System: Position Paper From ESPGHAN and EASL

  2018cites this paper
• Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study

  2018cites this paper
• Effect of Restriction of Foods with High Fructose Corn Syrup Content on Metabolic Indices and Fatty Liver in Obese Children

  2017cites this paper
• Diagnosis of non-alcoholic fatty liver disease in obese adolescents using non-invasive methods

  2017cites this paper
• The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

  2017cites this paper
• Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community

  2017cites this paper
• Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities

  2016cites this paper